Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (86)

2023

  1. A Study of the Prevalence of Asthma in the General Population in Spain

    Open Respiratory Archives, Vol. 5, Núm. 2

  2. A pulmonary rehabilitation program reduces hospitalizations in chronic obstructive pulmonary disease patients: A cost‑effectiveness study

    Annals of Thoracic Medicine, Vol. 18, Núm. 4, pp. 190-198

  3. Advances in inhaled antibiotics for management of respiratory tract infections

    Current opinion in pulmonary medicine, Vol. 29, Núm. 3, pp. 160-167

  4. Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review

    Respiratory Medicine, Vol. 214

  5. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 7, pp. 1934-1948

  6. Criteria to evaluate efficacy of biologics in asthma: a Global Asthma Association survey

    Expert Review of Respiratory Medicine, Vol. 17, Núm. 6, pp. 507-516

  7. Does asthma-bronchiectasis overlap syndrome (ABOS) really exist?

    Journal of Asthma, Vol. 60, Núm. 11, pp. 1935-1941

  8. Exacerbations Among Patients With Asthma Are Largely Dependent on the Presence of Multimorbidity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 4, pp. 281-288

  9. Factors Linked to Frequent Attendance in the Out-of-hospital Setting by Patients With Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 2, pp. 119-122

  10. Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 223-231

  11. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2732-2747

  12. Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?

    Journal of Thoracic Disease, Vol. 15, Núm. 2, pp. 711-717

  13. Occupation as a risk factor of small cell lung cancer

    Scientific Reports, Vol. 13, Núm. 1

  14. Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study

    Drugs, Vol. 83, Núm. 12, pp. 1111-1123